Parabilis Medicines, Inc. · NASDAQ:PBLS
Sebulsky Alan bought 17,500 Parabilis Medicines, Inc. shares (Form 4)
Traded Jun 12 to Jun 15, 2026 · Filed Jun 16, 2026
From Jun 12 to Jun 15, 2026, Sebulsky Alan (Director) bought 17,500 Parabilis Medicines, Inc. shares at an average US$27.06 for US$474K, leaving 30,000 shares. Filed Jun 16, 2026 (Form 4).
- Bought
- 17,500 shares
- Price
- US$27.06 average (US$26.00 to US$27.67)
- Value
- US$474K
- Holding after
- 30,000 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Buy | 8,435 | US$27.67 | 20,935 | Indirect |
| Jun 15, 2026 | Common Stock | Buy | 5,000 | US$26.00 | 25,935 | Indirect |
| Jun 15, 2026 | Common Stock | Buy | 4,065 | US$27.10 | 30,000 | Indirect |
Source
Related
- Parabilis Medicines, Inc.
- Sebulsky Alan
- Parabilis Medicines, Inc. shareholders
- Form 4 · Sebulsky Alan · Jun 15, 2026
- Schedule 13G · ARCH Venture Fund XII, L.P. · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Form 4 · Ra Capital Management, L.P. · Jul 22, 2026
- Form 4 · Soleus Capital Group, LLC · Jun 29, 2026
- Schedule 13D · Ra Capital Management, L.P. · Jun 18, 2026